UCB SA (CHIX:UCBb) Stock News, Headlines & Updates
UCB SA Stock News from GuruFocus
- 1
Jul 08, 2025
UCB extends its BIMZELX® "Get Yourself Back" direct-to-consumer campaign for the hidradenitis suppurativa community
PRNewswire • 7:00am
UCB extends its BIMZELX® "Get Yourself Back" direct-to-consumer campaign for the hidradenitis suppurativa community | UCBJY Stock News
GuruFocus News • 6:18am
Jun 27, 2025
UCB announces positive results from GEMZ Phase 3 study of fenfluramine in CDKL5 deficiency disorder
PRNewswire • 7:00am
UCBJF Reports Successful Phase 3 Study Results for CDKL5 Deficiency Disorder | UCBJF Stock News
GuruFocus News • 6:18am
UCB announces positive results from GEMZ Phase 3 study of fenfluramine in CDKL5 deficiency disorder | UCBJY Stock News
GuruFocus News • 6:16am
Jun 23, 2025
UCBJF Stock Upgraded by Morgan Stanley with Increased Price Target | UCBJF Stock News
GuruFocus News • 11:23am
Jun 20, 2025
UCB presents latest thymidine kinase 2 deficiency (TK2d) research at the United Mitochondrial Disease Foundation (UMDF) 2025 Conference
PRNewswire • 7:00am
UCBJF to Showcase TK2d Research at 2025 Mitochondrial Medicine Conference | UCBJF Stock News
GuruFocus News • 6:46am
UCB presents latest thymidine kinase 2 deficiency (TK2d) research at the United Mitochondrial Disease Foundation (UMDF) 2025 Conference | UCBJY Stock News
GuruFocus News • 6:16am
Jun 17, 2025
Inaugural 2025 UCB U.S. Myasthenia Gravis Scholarshipâ„¢ grants 15 scholarships to people impacted by myasthenia gravis in the U.S.
PRNewswire • 8:00am
Inaugural 2025 UCB U.S. Myasthenia Gravis Scholarshipâ„¢ grants 15 scholarships to people impacted by myasthenia gravis in the U.S. | UCBJY Stock News
GuruFocus News • 7:45am
Jun 12, 2025
UCB Announces Major U.S. Investment to Expand Biologics Manufacturing Capacity
PRNewswire • 12:00pm
UCB Announces Major U.S. Investment to Expand Biologics Manufacturing Capacity | UCBJY Stock News
GuruFocus News • 11:45am
Jun 11, 2025
BIMZELX® (bimekizumab-bkzx) Three-Year Data at EULAR 2025 Showed Lasting Efficacy and Control of Inflammation in Psoriatic Arthritis and Axial Spondyloarthritis
PRNewswire • 12:00pm
BIMZELX® (bimekizumab-bkzx) Three-Year Data at EULAR 2025 Showed Lasting Efficacy and Control of Inflammation in Psoriatic Arthritis and Axial Spondyloarthritis | UCBJY Stock News
GuruFocus News • 11:30am
May 19, 2025
UCB and Domino Data Lab Collaborate to Modernize Statistical Computing Environment in Life Sciences
PRNewswire • 12:00pm
UCB and Domino Data Lab Collaborate to Modernize Statistical Computing Environment in Life Sciences | UCBJY Stock News
GuruFocus News • 11:45am
Apr 28, 2025
UCBJF Faces Price Target Cut Amid New Tariff Concerns | UCBJF Stock News
GuruFocus News • 6:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news